16 de octubre de 2019
7 de septiembre de 2018

German Health Technology Assessment Body (IQWiG) Concludes Only Oncotype DX® Has Sufficient Evidence to Guide Breast Can

1. Sparano et al. New Engl J Med. 2018 Jul 12;379(2):111-121 2. EUCAN. 2012. Available at: http://eco.iarc.fr/EUCAN/CancerOne.aspx?Cancer=46&Gender=2 3. Paik et al. J Clin Oncol. 2006; Early Breast Cancer Trialists' Collaborative Group (EBCTCG) et al. Lancet. 2012. 4. Loncaster J et al, Eur J Surg Oncol 2017

Photo: https://mma.prnewswire.com/media/740946/Genomic_Health_Logo....

CONTACT: Federico Maiardi, Genomic Health, +41-79-138-1326,fmaiardi@genomichealth.com